サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1571988

論文診断の世界市場

Paper Diagnostics

出版日
ページ情報
英文 174 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.33円
論文診断の世界市場
出版日: 2024年10月18日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 174 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

論文診断の世界市場は2030年までに米国で138億米ドルに達する見込み

2023年に88億米ドルと推定される論文診断の世界市場は、2023年から2030年にかけてCAGR 6.6%で成長し、2030年には138億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるラテラルフローアッセイキットは、CAGR 6.2%を記録し、分析期間終了までに67億米ドルに達すると予測されます。ディップスティック分野の成長率は、分析期間中CAGR 7.4%と推定されます。

米国市場は24億米ドルと推定、中国はCAGR6.2％で成長予測

米国の論文診断市場は2023年に24億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに22億米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは6.2%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ5.8%と5.6%と予測されています。欧州では、ドイツがCAGR 5.1%で成長すると予測されています。

世界の論文診断市場- 主要動向と促進要因のまとめ

論文診断とは何か、なぜヘルスケアで人気を集めているのか？

論文診断とは、医療検査や病気の検出に紙ベースのデバイスを使用することを指します。これらの機器は一般的に、安価で使いやすく、使い捨てが可能なセルロースやその他の多孔質材料から作られています。論文診断は、特に資源が限られた環境において、従来の検査室ベースの検査に代わる費用対効果の高い方法として人気を博しています。妊娠検査やマラリア、COVID-19、HIVのような感染症の迅速診断検査のようなラテラル・フロー・アッセイによく使用されます。これらの装置はシンプルで持ち運びが容易なため、タイムリーな診断が重要なポイントオブケア検査に最適です。さらに、論文診断は生分解性で環境にやさしく、操作に必要な試薬や機器も最小限で済みます。

技術の進歩は論文診断の能力をどのように高めていますか？

技術の進歩は論文診断の用途を大きく広げました。マイクロ流体工学の革新は、紙にエッチングされた流路に少量の流体を流すことで、複数の検査を同時に行うことができる、より複雑な診断法の開発を可能にしました。論文診断に比色法、電気化学的検出法、蛍光検出法が組み込まれたことで、感度と精度が向上し、より信頼性の高い結果が得られるようになった。さらに、血液、唾液、尿中の特定のバイオマーカーを検出できる紙ベースのバイオセンサーの開発により、論文診断は病気の早期発見やモニタリングのための強力なツールとなりつつあります。これらの進歩により、個別化ヘルスケアの新たな可能性が開かれ、個人が自宅で診断テストを行い、検査室を介さずに即座に結果を受け取ることができるようになった。

世界のヘルス・イニシアティブと遠隔ヘルスケア動向はどのように市場を形成しているか？

技術革新は、主にマイクロ流体工学、バイオセンサー、検出方法の進歩を通じて、論文診断業界を変革しています。マイクロ流体工学は、小型で持ち運び可能なペーパープラットフォーム上で複雑なアッセイを処理できるデバイスの開発を可能にしました。このような進歩により、複数の検査を同時に行うことができる装置の作成が可能になり、論文診断の汎用性が大幅に向上しました。さらに、論文診断に組み込まれたバイオセンサーの使用により、感染症から糖尿病のような慢性疾患まで、検出可能な病態の範囲が広がりました。比色、蛍光、電気化学的検出技術の統合は、これらの検査の精度と信頼性をさらに向上させ、先進国市場と新興国市場の両方でその魅力を高めています。このような技術的飛躍的進歩により、低資源環境でも使用可能で、医療の現場で迅速かつ信頼性の高い結果を提供できる、手頃な価格の携帯型診断ツールの設計が可能になった。

論文診断市場の成長の原動力は？

論文診断の需要は、遠隔地や十分なサービスを受けていない地域におけるヘルスケアアクセスの改善に焦点を当てた世界ヘルスイニシアチブの影響を大きく受けています。世界保健機関（WHO）やNGOなどの組織は、医療インフラが限られている地域でも使用できる手頃な価格の診断ツールをますます提唱しています。論文診断は、低コストで持ち運びが容易であるため、従来の検査室での検査にアクセスできなかったり、手が届かなかったりするこうした環境に適しています。これらのツールは、マラリア、結核、HIVのような病気をタイムリーに発見するために極めて重要であり、感染症の蔓延を抑えるのに役立ちます。さらに、COVID-19の大流行は、在宅検査と遠隔医療の重要性を浮き彫りにし、論文診断の採用を加速させました。

特にヘルスケア・インフラへのアクセスが限られている地域では、ポイントオブケア診断に対する需要が高まっており、紙ベースの診断機器の採用に拍車をかけています。マイクロ流体工学、バイオセンサー、検出方法の技術的進歩により、紙ベースのプラットフォームで実施可能な検査の感度、精度、範囲が大幅に向上しています。さらに、手頃な価格で持続可能なヘルスケアソリューションの世界の推進により、費用対効果が高く、携帯可能で環境に優しい論文診断への需要が高まっています。遠隔ヘルスケアや個別化医療へのシフト、感染症や慢性疾患の有病率の上昇も、市場の成長に寄与しています。政府、NGO、ヘルスケア機関が、特に低リソース環境におけるヘルスケアアクセスの改善に投資を続けているため、論文診断市場は大きく拡大すると予想されます。

調査対象企業の例（注目の44社）

  • Abcam PLC
  • Abingdon Health Ltd.
  • Acon Laboratories, Inc.
  • Alere, Inc.
  • Arkray, Inc.
  • BBI Solutions
  • Bioporto Diagnostics A/S
  • Bio-Rad Laboratories, Inc.
  • Chembio Diagnostic Systems, Inc.
  • Cytodiagnostics Inc.
  • DCN Diagnostics
  • MilliporeSigma
  • NanoHybrids
  • SD Biosensor, Inc.
  • Siemens Healthineers
  • SurModics, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP13853

Global Paper Diagnostics Market to Reach US$13.8 Billion by 2030

The global market for Paper Diagnostics estimated at US$8.8 Billion in the year 2023, is expected to reach US$13.8 Billion by 2030, growing at a CAGR of 6.6% over the analysis period 2023-2030. Lateral Flow Assay Kits, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$6.7 Billion by the end of the analysis period. Growth in the Dipsticks segment is estimated at 7.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.4 Billion While China is Forecast to Grow at 6.2% CAGR

The Paper Diagnostics market in the U.S. is estimated at US$2.4 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$2.2 Billion by the year 2030 trailing a CAGR of 6.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.8% and 5.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.1% CAGR.

Global Paper Diagnostics Market – Key Trends & Drivers Summarized

What Are Paper Diagnostics and Why Are They Gaining Traction in Healthcare?

Paper diagnostics refers to the use of paper-based devices for medical testing and disease detection. These devices are typically made from cellulose or other porous materials that are inexpensive, easy to use, and disposable. Paper diagnostics has gained popularity, particularly in resource-limited settings, as they provide a cost-effective alternative to traditional laboratory-based tests. They are often used in lateral flow assays, such as pregnancy tests or rapid diagnostic tests for infectious diseases like malaria, COVID-19, or HIV. The simplicity and portability of these devices make them ideal for point-of-care testing, where timely diagnosis is crucial. In addition, paper diagnostics are environmentally friendly, being biodegradable and requiring minimal reagents or equipment for operation.

How Are Technological Advancements Enhancing the Capabilities of Paper Diagnostics?

Technological advancements have greatly expanded the applications of paper diagnostics. Innovations in microfluidics, where small volumes of fluids are directed through channels etched into paper, have made it possible to develop more complex diagnostics that can perform multiple tests simultaneously. The incorporation of colorimetric, electrochemical, and fluorescent detection methods into paper diagnostics has improved their sensitivity and accuracy, allowing for more reliable results. In addition, the development of paper-based biosensors, which can detect specific biomarkers in blood, saliva, or urine, is making paper diagnostics a powerful tool for early disease detection and monitoring. These advancements have opened up new possibilities for personalized healthcare, allowing individuals to perform diagnostic tests at home and receive instant results without the need for a laboratory.

How Are Global Health Initiatives and Remote Healthcare Trends Shaping the Market?

Technological innovations are transforming the paper diagnostics industry, primarily through advancements in microfluidics, biosensors, and detection methods. Microfluidics has allowed the development of devices that can handle complex assays on a small, portable paper platform. These advancements enable the creation of devices that can simultaneously conduct multiple tests, significantly improving the versatility of paper diagnostics. Moreover, the use of biosensors embedded in paper diagnostics has expanded the range of detectable conditions, from infectious diseases to chronic illnesses like diabetes. The integration of colorimetric, fluorescent, and electrochemical detection techniques further improves the accuracy and reliability of these tests, enhancing their appeal in both developed and developing markets. These technological breakthroughs make it possible to design affordable, portable diagnostic tools that can be used in low-resource settings and provide quick, reliable results at the point of care.

What Is Driving Growth in the Paper Diagnostics Market?

The demand for paper diagnostics is heavily influenced by global health initiatives that focus on improving healthcare access in remote and underserved regions. Organizations such as the World Health Organization (WHO) and NGOs are increasingly advocating for affordable diagnostic tools that can be used in areas with limited medical infrastructure. Paper diagnostics, being low-cost and easy to transport, are well-suited to these environments, where traditional laboratory tests may be inaccessible or unaffordable. These tools are crucial for the timely detection of diseases like malaria, tuberculosis, and HIV, helping to curb the spread of infectious diseases. Additionally, the COVID-19 pandemic highlighted the importance of at-home testing and telemedicine, accelerating the adoption of paper diagnostics.

The increasing demand for point-of-care diagnostics, particularly in regions with limited access to healthcare infrastructure, has fueled the adoption of paper-based diagnostic devices. Technological advancements in microfluidics, biosensors, and detection methods have significantly improved the sensitivity, accuracy, and range of tests that can be performed on paper-based platforms. Furthermore, the global push for affordable and sustainable healthcare solutions has increased demand for paper diagnostics, which are cost-effective, portable, and environmentally friendly. The shift toward remote healthcare and personalized medicine, as well as the rising prevalence of infectious diseases and chronic conditions, are also contributing to market growth. As governments, NGOs, and healthcare organizations continue to invest in improving healthcare access, particularly in low-resource settings, the paper diagnostics market is expected to expand significantly.

Select Competitors (Total 44 Featured) -

  • Abcam PLC
  • Abingdon Health Ltd.
  • Acon Laboratories, Inc.
  • Alere, Inc.
  • Arkray, Inc.
  • BBI Solutions
  • Bioporto Diagnostics A/S
  • Bio-Rad Laboratories, Inc.
  • Chembio Diagnostic Systems, Inc.
  • Cytodiagnostics Inc.
  • DCN Diagnostics
  • MilliporeSigma
  • NanoHybrids
  • SD Biosensor, Inc.
  • Siemens Healthineers
  • SurModics, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Paper Diagnostics - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Low-Cost, Point-of-Care Testing Drives Growth in the Paper Diagnostics Market
    • Increasing Focus on Infectious Disease Testing Expands Market Opportunities for Paper-Based Diagnostic Tools
    • Technological Advancements in Microfluidics and Biosensors Enhance the Sensitivity and Accuracy of Paper Diagnostics
    • Growing Popularity of Home Testing Solutions Fuels Demand for User-Friendly, Disposable Paper Diagnostics
    • Rising Consumer Interest in Personalized Medicine and At-Home Diagnostics Strengthens the Business Case for Paper Diagnostics
    • Technological Innovations in Colorimetric and Electrochemical Detection Methods Improve the Accuracy of Paper-Based Tests
    • Growing Need for Rapid Testing During Public Health Crises Fuels Demand for Scalable Paper Diagnostics
    • Increasing Use of Paper Diagnostics in Disease Monitoring and Management Expands Market Potential in Chronic Disease Segments
    • Rising Focus on Sustainability and Biodegradability in Medical Devices Drives Adoption of Paper-Based Diagnostic Solutions
    • Technological Innovations in Immunoassay and Lateral Flow Techniques Enhance the Versatility and Speed of Paper Diagnostics
    • Growing Adoption of Paper Diagnostics in Remote and Resource-Limited Regions Strengthens Global Healthcare Access
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Paper Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Paper Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Paper Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Paper Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Lateral Flow Assay Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Lateral Flow Assay Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Lateral Flow Assay Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Dipsticks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Dipsticks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Dipsticks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Home Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Home Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Home Healthcare by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Paper Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Paper Diagnostics by Product - Percentage Breakdown of Value Sales for Lateral Flow Assay Kits, Dipsticks and Other Products for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Paper Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Healthcare and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Paper Diagnostics by Product - Percentage Breakdown of Value Sales for Lateral Flow Assay Kits, Dipsticks and Other Products for the Years 2014, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Paper Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Healthcare and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Paper Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Paper Diagnostics by Product - Percentage Breakdown of Value Sales for Lateral Flow Assay Kits, Dipsticks and Other Products for the Years 2014, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Paper Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Healthcare and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Paper Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Paper Diagnostics by Product - Percentage Breakdown of Value Sales for Lateral Flow Assay Kits, Dipsticks and Other Products for the Years 2014, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Paper Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Healthcare and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Paper Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Paper Diagnostics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Paper Diagnostics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Paper Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Paper Diagnostics by Product - Percentage Breakdown of Value Sales for Lateral Flow Assay Kits, Dipsticks and Other Products for the Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Paper Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Healthcare and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Paper Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Paper Diagnostics by Product - Percentage Breakdown of Value Sales for Lateral Flow Assay Kits, Dipsticks and Other Products for the Years 2014, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Paper Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Healthcare and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Paper Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Paper Diagnostics by Product - Percentage Breakdown of Value Sales for Lateral Flow Assay Kits, Dipsticks and Other Products for the Years 2014, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Paper Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Healthcare and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Paper Diagnostics by Product - Percentage Breakdown of Value Sales for Lateral Flow Assay Kits, Dipsticks and Other Products for the Years 2014, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Paper Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Healthcare and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Paper Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Paper Diagnostics by Product - Percentage Breakdown of Value Sales for Lateral Flow Assay Kits, Dipsticks and Other Products for the Years 2014, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Paper Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Healthcare and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Rest of Europe Historic Review for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Rest of Europe 16-Year Perspective for Paper Diagnostics by Product - Percentage Breakdown of Value Sales for Lateral Flow Assay Kits, Dipsticks and Other Products for the Years 2014, 2024 & 2030
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Rest of Europe 16-Year Perspective for Paper Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Healthcare and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Paper Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific Historic Review for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Asia-Pacific 16-Year Perspective for Paper Diagnostics by Product - Percentage Breakdown of Value Sales for Lateral Flow Assay Kits, Dipsticks and Other Products for the Years 2014, 2024 & 2030
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Asia-Pacific 16-Year Perspective for Paper Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Healthcare and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of World Historic Review for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of World 16-Year Perspective for Paper Diagnostics by Product - Percentage Breakdown of Value Sales for Lateral Flow Assay Kits, Dipsticks and Other Products for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of World Historic Review for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of World 16-Year Perspective for Paper Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Healthcare and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION